Instituto de Medicina Regenerativa Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2020
NCT04456361
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Instituto de Medicina Regenerativa